Apr 8, 2013
Lytix Biopharma attended the American Association for Cancer Research (AACR) annual meeting

Lytix Biopharma presented 2 posters at the American Association for Cancer Research (AACR) annual meeting in Washington DC April 6-10 2013.

Poster 474 Complete regression and long-term specific protective immune responses obtained in rodent tumor models after intratumoral treatment with LTX-315. Ø. Rekdal, G. Kvalheim, PD. Line, B. Rolstad, K. Camilio, G. Berge, J. Nestvold, W. Meng Yu, J. Shi, A. Areffard, B. Sveinbjørnsson.

Poster 477 Long-term protection against B16F1 melanoma upon vaccination with tumor cell lysate combined with LTX-315 as a novel adjuvant. Gerd Berge, Ketil Camilio, Øystein Rekdal and Ali Areffard.
  
There was great interest for both posters and Lytix Biopharma received good feedback.
  
  
  
  
Back